|
1
|
Tabayoyong W and Abouassaly R: Prostate
cancer screening and the associated controversy. Surg Clin North
Am. 95:1023–1039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giovannucci E: Medical history and
etiology of prostate cancer. Epidemiol Rev. 23:159–162. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Verma A, St Onge J, Dhillon K and
Chorneyko A: PSA density improves prediction of prostate cancer.
Can J Urol. 21:7312–7321. 2014.PubMed/NCBI
|
|
5
|
Harris WP, Mostaghel EA, Nelson PS and
Montgomery B: Androgen deprivation therapy: Progress in
understanding mechanisms of resistance and optimizing androgen
depletion. Nat Clin Pract Urol. 6:76–85. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, et al: miR-143 decreases prostate
cancer cells proliferation and migration and enhances their
sensitivity to docetaxel through suppression of KRAS. Mol Cell
Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doench JG and Sharp PA: Specificity of
microRNA target selection in translational repression. Genes Dev.
18:504–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and
Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates
G1/S transition of human hepatocellular carcinoma cells.
Hepatology. 50:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujita Y, Kojima T, Kawakami K, Mizutani
K, Kato T, Deguchi T and Ito M: miR-130a activates apoptotic
signaling through activation of caspase-8 in taxane-resistant
prostate cancer cells. Prostate. 75:1568–1578. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu XD, Zhang LY, Zhu TC, Zhang RF, Wang
SL and Bao Y: Overexpression of miR-34c inhibits high
glucose-induced apoptosis in podocytes by targeting Notch signaling
pathways. Int J Clin Exp Pathol. 8:4525–4534. 2015.PubMed/NCBI
|
|
12
|
Wang X, Qiu W, Zhang G, Xu S, Gao Q and
Yang Z: MicroRNA-204 targets JAK2 in breast cancer and induces cell
apoptosis through the STAT3/BCl-2/survivin pathway. Int J Clin Exp
Pathol. 8:5017–5025. 2015.PubMed/NCBI
|
|
13
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Zhang T, Ti X, Shi J, Wu C, Ren X
and Yin H: Curcumin promotes apoptosis in A549/DDP
multidrug-resistant human lung adenocarcinoma cells through an
miRNA signaling pathway. Biochem Biophys Res Commun. 399:1–6. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hossini AM and Eberle J: Apoptosis
induction by Bcl-2 proteins independent of the BH3 domain. Biochem
Pharmacol. 76:1612–1619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li CY, Chu JY, Yu JK, Huang XQ, Liu XJ,
Shi L, Che YC and Xie JY: Regulation of alternative splicing of
Bcl-x by IL-6, GM-CSF and TPA. Cell Res. 14:473–479. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J and Yuan J: Caspases in apoptosis and
beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H,
Xiao J, Shan H, Wang Z and Yang B: The muscle-specific microRNAs
miR-1 and miR-133 produce opposing effects on apoptosis by
targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci.
120:3045–3052. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Revil T, Toutant J, Shkreta L, Garneau D,
Cloutier P and Chabot B: Protein kinase C-dependent control of
Bcl-x alternative splicing. Mol Cell Biol. 27:8431–8441. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boise LH, González-García M, Postema CE,
Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB:
bcl-x, a bcl-2-related gene that functions as a dominant regulator
of apoptotic cell death. Cell. 74:597–608. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Organization WH: National cancer control
programmes: Policies and managerial guidelines. World Health
Organization; 2002
|
|
23
|
Chen L, Lü MH, Zhang D, Hao NB, Fan YH, Wu
YY, Wang SM, Xie R, Fang DC, Zhang H, et al: miR-1207-5p and
miR-1266 suppress gastric cancer growth and invasion by targeting
telomerase reverse transcriptase. Cell Death Dis. 5:e10342014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Horsham JL, Kalinowski FC, Epis MR, Ganda
C, Brown RA and Leedman PJ: Clinical potential of microRNA-7 in
cancer. J Clin Med. 4:1668–1687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z and Rana TM: Therapeutic targeting of
microRNAs: Current status and future challenges. Nat Rev Drug
Discov. 13:622–638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang R, Tian S, Wang HB, Chu DP, Cao JL,
Xia HF and Ma X: MiR-185 is involved in human breast carcinogenesis
by targeting Vegfa. FEBS Lett. 588:4438–4447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Imam JS, Buddavarapu K, Lee-Chang JS,
Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses
tumor growth and progression by targeting the Six1 oncogene in
human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Q, Yu L, Qin D, Huang R, Jiang X,
Zou C, Tang Q, Chen Y, Wang G, Wang X and Gao X: Role of
microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One.
10:e01206982015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo R, Wang Y, Shi WY, Liu B, Hou SQ and
Liu L: MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces
cell apoptosis in SW1990 pancreatic cancer cells through
mitochondria mediated pathway. Molecules. 17:14733–14747. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y
and Pei X: MicroRNA-125b induces cancer cell apoptosis through
suppression of Bcl-2 expression. J Genet Genomics. 39:29–35. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of BCL2 and the
nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105:265–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
